Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency
Stéphanie E. Reitsma, Lori A. Holle, Emma G. Bouck, Dougald M. Monroe, Alan E. Mast, John Burthem, Paula Bolton‐Maggs, Gillian Gidley, Alisa S. Wolberg
Topics & Concepts
Risk factorTissue factor pathway inhibitorMedicineInternal medicineTissue factorGastroenterologyCoagulationCoagulation, Bradykinin, Polyphosphates, and AngioedemaHemophilia Treatment and ResearchBlood properties and coagulation